Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DC-CIK plus Chemotherapy in Gastric Cancer
NCT02504229Phase 2Unknown
- Sponsor
- Bodihekang
- Start
- Nov 2014
- Primary completion
- Jul 2018
- Modality
- Prophylactic Vaccines, Whole Cell Cancer Vaccines, Dendritic Cell Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of dendritic cell vaccine + cytokine-induced killer cells in gastric adenocarcinoma, sponsored by Bodihekang. Status: unknown.
02
Drugs
dendritic cell vaccine + cytokine-induced killer cells
03
Conditions
gastric adenocarcinoma
Beyond the preview
Go deeper on NCT02504229.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02504229.